LAUREN HATHORN: Open Payments
NPI 1770320566 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,167 in 51 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $462 · 2025 $1,167
Food & beverage: $1,083Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $201 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $189 |
| Ipsen Biopharmaceuticals, Inc | 5 | $125 |
| Aimmune Therapeutics, Inc. | 5 | $115 |
| GENZYME CORPORATION | 3 | $92 |
| Phathom Pharmaceuticals, Inc. | 4 | $81 |
| Lilly USA, LLC | 4 | $80 |
| ABBVIE INC. | 4 | $75 |
| Gilead Sciences, Inc. | 3 | $72 |
| Celltrion USA Inc. | 2 | $34 |
Products named: TREMFYA, ENTYVIO, IQIRVO, DUPIXENT, ZENPEP, VOQUEZNA, OMVOH, VEGZELMA.
Industry payments across AZ — which companies pay providers there.
